WinstonWınston
NewGenIvf Group Limited logo

NewGenIvf Group Limited

NIVFW
19
Medical - Care Facilities · Healthcare
Price
$0.02
-0.01 (-37.14%)
Market Cap
$50,023
Exchange
NASDAQ Capital Market
Winston Score
19
Winston is worried
Weak fundamentals across most pillars.
Data as of Jul 28, 2026 · filings through Dec 31, 2025

Share count rising — dilution

+124.4% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 87K (2021) → 196K (2025)

NewGenIvf Group Limited is a fertility clinic operator based in Southeast Asia. The company runs IVF (in vitro fertilization) clinics that help people who are having trouble getting pregnant. Its main customers are couples and individuals seeking fertility treatments, and it operates in the medical care facilities industry with a focus on reproductive medicine.

The company earns money by charging patients for fertility procedures, consultations, and related medical services. NewGenIvf operates primarily in Thailand and other parts of Southeast Asia, where demand for fertility services has been growing. The company is small, with a market cap near zero, and its financials show significant losses — the operating margin is deeply negative, meaning it spends far more than it earns. The main risk is that the company must scale its clinic network and patient volume quickly enough to cover high fixed costs before it runs out of capital to fund operations.

Winston Score History

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
36.8%
Modest — 36.8% gross margin
Operating Margin
-349.1%
Losing money on operations — -349.1%
ROCE
-16.1%
Weak — -16.1% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
N/A
Data not available
EPS YoY
N/A
Data not available
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.16
Conservative — low debt load (0.16)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
0.0x
Attractive valuation — P/E 0.0

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial